Latest Breaking News On - Chintu patel - Page 1 : comparemela.com

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript

Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.29824 EPS, expectations were $0.09. Amneal Pharmaceuticals, Inc.

South-africa
Mexico
China
Canada
India
Philippines
California
United-states
New-jersey
State-of-california
Saudi-arabia
America

Amneal Reports First Quarter 2024 Financial Results

‒ Q1 2024 Net Revenue of $659 million; GAAP Net Loss of $92 million; Diluted Loss per Share of $0.30 ‒ ‒ Adjusted EBITDA of $152 million; Adjusted Diluted EPS of $0.14 ‒ ‒ Company has.

United-states
American
America
Chintu-patel
Amneal-pharmaceuticals-inc
Kashiv-specialty-pharmaceuticals
Exchange-commission
Amneal-group
Drug-administration
Nasdaq
Saol-international
Amneal-pharmaceuticals

California settles with drugmaker it's working with on overdose meds

California settles with drugmaker it's working with on overdose meds
sfchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfchronicle.com Daily Mail and Mail on Sunday newspapers.

United-states
New-york
New-jersey
Sacramento
California
Americans
America
Tasos-konidaris
Rodger-butler
Mark-ghaly
Rob-bonta
Chirag-patel

FDA approves generic over-the-counter naloxone nasal spray

FDA approves generic over-the-counter naloxone nasal spray
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Chintu-patel
Amneal-pharmaceuticals
Amneal-pharmaceuticals-inc

FDA Approves Over-the-Counter Naloxone Nasal Spray for Opioid Overdose

Naloxone hydrochloride (Amneal Pharmaceuticals Inc) is the generic equivalent to OTC narcan (Emergent).

Chintu-patel
Amneal-pharmaceuticals-inc